(Q42631467)

4 November 2017

title

Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression (English)

1 reference

4 November 2017

1 reference

Michael Liebrenz

1

1 reference

4 November 2017

Rudolf Stohler

series ordinal

2

1 reference

4 November 2017

Alain Borgeat

series ordinal

3

1 reference

4 November 2017

publication date

1 January 2009

1 reference

World Journal of Biological Psychiatry

4 November 2017

published in

1 reference

4 November 2017

volume

10

1 reference

4 November 2017

issue

4 Pt 2

1 reference

4 November 2017

page(s)

640-643

1 reference

Antidepressant effects of ketamine in depressed patients

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15622970701420481

Depression: comfortably numb

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701420481

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701420481

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701420481

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701420481

Dopaminergic-based pharmacotherapies for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701420481

Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701420481

The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701420481

An open-label trial of riluzole in patients with treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701420481

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970701420481

10.1080/15622970701420481

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference